A Philadelphia jury awarded $500,000 on Dec. 11 to the plaintiff in the fourth Risperdal trial to go to a verdict.
After about six hours of deliberating, the 12-member jury in Stange v. Janssen Pharmaceuticals found that Janssen Pharmaceuticals negligently failed to warn about the antipsychotic drug, and that the negligence caused the injuries of plaintiff Timothy Stange. While the jury was unanimous on the issues of damages and failure to warn, two jurors found for Janssen on the causation issue.
